Medical Plan Options Clause Samples

The "Medical Plan Options" clause defines the range of healthcare coverage choices available to eligible individuals under an agreement or employment arrangement. It typically outlines the different types of medical insurance plans offered, such as HMOs, PPOs, or high-deductible health plans, and may specify eligibility criteria, enrollment periods, and the process for selecting or changing plans. This clause ensures that individuals are informed about their healthcare coverage options and can make informed decisions based on their needs, thereby promoting transparency and supporting employee well-being.
Medical Plan Options. (a) A traditional Kaiser Foundation health maintenance organization plan (b) A traditional non-Kaiser Foundation health maintenance organization plan (c) Up to two (2) high deductible health plan options, with a voluntary health savings account.
Medical Plan Options. (a) A traditional ▇▇▇▇▇▇ Foundation health maintenance organization plan (b) A traditional non-▇▇▇▇▇▇ Foundation health maintenance organization plan (c) Up to two (2) high-deductible health plan options, with a voluntary health savings account.
Medical Plan Options. All eligible retirees as described in Section 2501 above shall have a one‐time option, which must be exercised during the ninety (90) day period prior to exhaustion of COBRA and Cal‐COBRA, to enroll/continue in the Basic HMO medical plan available to Sharp employees. The retiree may select employee‐only, employee and spouse, or employee and dependents coverage depending on the employee's coverage at the time Cal‐COBRA is exhausted. The Employer will send a written notice to the eligible retiree, at his or her last known address, within thirty (30) days prior to the commencement of the ninety (90) day period referenced above, advising the Employee that they have such option as described above.
Medical Plan Options. Effective July 1, 2013, secretaries will have the choice of the following plan options: 1. Direct Access 10 2. POS 8 20/20 3. EPO